Striking Dichotomy of PD-L1 and PD-L2 Pathways in Regulating Alloreactive CD4+ and CD8+ T Cells In Vivo
Open Access
- 1 December 2007
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (12) , 2683-2692
- https://doi.org/10.1111/j.1600-6143.2007.01999.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathwayThe Journal of Experimental Medicine, 2006
- Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockadeTrends in Molecular Medicine, 2006
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) MiceThe Journal of Experimental Medicine, 2003
- Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune EncephalomyelitisThe Journal of Experimental Medicine, 2003
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002
- Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and TransplantationAnnual Review of Immunology, 2001
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.Journal of Clinical Investigation, 1997